论文部分内容阅读
肉豆蔻醚酸甲酯(Myristicic acid met-hyl ester,I)是治疗肝炎新药联苯双酯的关键中间体,以没食子酸为原料,有三条合成路线。由于原料受自然资源的限制,且合成
Myristic acid met-hyl ester (I) is a key intermediate for the treatment of bifendate, a novel hepatitis drug. There are three synthetic routes to gallic acid. Due to natural resources constraints of raw materials, and synthesis